[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Cyteir Therapeutics Inc (CYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-1999	12-1998	12-1997	12-1996	12-1995
Assets
Current Assets
Cash & Cash Equivalents	N/A	1,700	6,400	20,400	12,000
Receivables	N/A	241,300	226,900	206,500	216,800
Inventories	N/A	140,500	131,900	105,600	88,100
Other current assets	0	94,100	87,600	83,800	87,100
TOTAL	$N/A	$477,600	$452,800	$416,300	$404,000

Non-Current Assets
PPE Net	N/A	667,500	629,700	582,200	605,700
Investments And Advances	0	0	141,100	143,700	155,200
Other Non-Current Assets	0	585,500	390,500	118,900	128,900
TOTAL	$N/A	$1,253,000	$1,161,300	$844,800	$889,800

Total Assets	$N/A	$1,730,600	$1,614,100	$1,261,100	$1,293,800

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	0	99,900	116,300	101,300	98,300
Accrued Expenses	N/A	243,900	239,000	205,100	218,300
TOTAL	$N/A	$394,400	$375,000	$312,800	$317,700

Non-Current Liabilities
Long Term Debt	N/A	419,500	324,000	89,000	66,000
Other Non-Current Liabilities	0	485,700	527,700	544,900	567,200
TOTAL	$N/A	$905,200	$851,700	$633,900	$633,200

Total Liabilities	$N/A	$1,299,600	$1,226,700	$946,700	$950,900

Shareholders' Equity
Common Shares	N/A	500	500	500	200
Retained earnings	N/A	456,200	331,500	217,900	117,800
Other shareholders' equity	0	-7,100	-10,500	6,300	2,300
TOTAL	$N/A	$431,000	$387,400	$314,400	$342,900

Total Liabilities And Equity	$0	$1,730,600	$1,614,100	$1,261,100	$1,293,800